Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 95,386 | 27,896 | 19,473 | 69,870 | 90,456 |
| Marketable Securities | 9,198 | 16,288 | 43,260 | N/A | N/A |
| Receivables | 9,168 | 7,898 | 33,936 | 23,217 | 8,006 |
| Inventories | 29,013 | 27,164 | 34,904 | 28,345 | 11,602 |
| Other current assets | 0 | 36,691 | 0 | 0 | 0 |
| TOTAL | $148,761 | $120,604 | $138,452 | $126,088 | $114,712 |
| Non-Current Assets | |||||
| PPE Net | 6,084 | 5,689 | 23,638 | 17,657 | 10,120 |
| Investments And Advances | 5,623 | 5,617 | 6,401 | 4,372 | 5,872 |
| Intangibles | 221,863 | 224,300 | 256,829 | 376,890 | 89,498 |
| Other Non-Current Assets | 17,156 | 56,504 | 24,909 | 29,279 | 14,627 |
| TOTAL | $250,726 | $292,110 | $311,777 | $428,198 | $120,117 |
| Total Assets | $399,487 | $412,714 | $450,229 | $554,286 | $234,829 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 10,943 | 6,285 | 1,814 | 862 | 614 |
| Accounts payable and accrued liabilities | 3,573 | 2,270 | 15,367 | 14,945 | 3,672 |
| Accrued Expenses | 12,451 | 9,121 | 9,782 | 6,870 | 4,543 |
| Other current liabilities | 4,256 | 4,400 | 14,601 | 17,116 | 5,629 |
| TOTAL | $32,734 | $42,178 | $44,582 | $42,700 | $15,573 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,997 | 24,064 | 23,793 | 6,353 | 655 |
| Other Non-Current Liabilities | 12,723 | 8,695 | 17,290 | 21,408 | 13,343 |
| TOTAL | $17,844 | $32,873 | $41,459 | $33,539 | $14,010 |
| Total Liabilities | $50,578 | $75,051 | $86,041 | $76,239 | $29,583 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 47,000 | 45,300 | 43,212 | 42,095 | 33,401 |
| Common Shares | 47 | 45 | 43 | 42 | 33 |
| Retained earnings | -335,101 | -314,917 | -246,915 | -107,110 | -97,385 |
| Other shareholders' equity | 24 | -345 | -679 | -282 | 0 |
| TOTAL | $348,909 | $337,663 | $364,188 | $478,047 | $205,246 |
| Total Liabilities And Equity | $399,487 | $412,714 | $450,229 | $554,286 | $234,829 |